Phase 2 Stomach Cancer Trial, Recruiting NCT05715931 Sponsor: Yu jiren Condition: Stomach Cancer
Back to Stomach Cancer

Phase 2 Stomach Cancer Trial, Recruiting

NCT05715931
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to take part voluntarily and have signed the consent form after being fully informed about the study.
  • You are between 18 and 80 years old (any gender).
  • You have been confirmed by a tissue test (biopsy) to have stomach cancer or cancer at the junction of the esophagus and stomach (a specific type called adenocarcinoma).
  • Your cancer tests show a high level of a protein called HER2, confirmed through specific laboratory tests on your biopsy tissue.
  • Your cancer has been staged as locally advanced (not yet spread to distant parts of the body), based on standard staging guidelines.
  • You are in good enough general health to carry out daily activities, as measured by a standard doctor's assessment done within 7 days before starting treatment.
  • Your doctors expect you to live for at least 6 months.
  • You agree to provide tissue samples from your biopsy and surgery, as well as blood, stool, and urine samples for research testing.
  • Your blood test results show that your blood counts, liver, kidneys, blood clotting, and heart function are all within acceptable ranges (as measured within 14 days before starting treatment).
  • If you are a woman who could become pregnant, you must have a negative pregnancy test within 7 days before starting treatment, not be breastfeeding, and agree to use reliable contraception or abstain from sex for a set period after treatment ends.
  • If you are a man, you must agree to use reliable contraception or abstain from sex for a set period after treatment ends.

Who may not be able to join:

  • You have previously received any treatment for stomach cancer, including surgery, chemotherapy, radiotherapy, targeted therapy, or immunotherapy.
  • You have had or currently have another active cancer in the past 5 years (some very early or treated skin and reproductive cancers may be exceptions — confirm with trial site).
  • You have a blockage in your stomach outlet, are unable to swallow/eat by mouth, or have serious bleeding in your digestive system.
  • You have had a heart attack in the last 6 months, have uncontrolled chest pain, a heart rhythm problem requiring treatment (such as a pacemaker), or have moderate-to-severe heart failure.
  • You have ongoing chronic diarrhea (watery, 5 or more times per day).
  • You have an active infection requiring medical treatment within 14 days before starting the trial.
  • You have active tuberculosis (TB).
  • You have been diagnosed with, or have symptoms of, a lung condition called interstitial lung disease.
  • You test positive for HIV, hepatitis B, or hepatitis C.
  • You need long-term use of steroid medications (above a certain dose) or other medicines that suppress the immune system, within 14 days before starting or during the trial.
  • You have had a severe allergic reaction to any antibody-based medication in the past or currently.
  • You have an active autoimmune disease (some conditions like type 1 diabetes or an underactive thyroid managed only with hormone replacement may be exceptions — confirm with trial site).
  • You have received a live vaccine within 28 days before starting the trial or during the trial (standard inactivated flu vaccines are generally allowed — confirm with trial site).
  • You have a history of receiving a donated organ transplant or donated stem cell transplant.
  • You have a serious ongoing illness (such as uncontrolled diabetes or high blood pressure) that has not responded well to treatment.
  • Your doctor judges that you have other serious physical or mental health conditions, or abnormal test results, that make participation unsafe or unsuitable.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Jiren Yu, First Affiliated Hospital of Zhejiang University

Phone: 0086-0571-87237931

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Yu jiren
Registry
ClinicalTrials.gov
Start date
28 February 2023
Est. completion
1 March 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Rate of pathological complete responses (pCR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov